Wu YL - Search Results

1

Targeting peroxiredoxins against leukemia.

Liu CX, Zhou HC, Yin QQ, Wu YL, Chen GQ. Liu CX, et al. Among authors: wu yl. Exp Cell Res. 2013 Jan 15;319(2):170-6. doi: 10.1016/j.yexcr.2012.06.013. Epub 2012 Jun 20. Exp Cell Res. 2013. PMID: 22728267 Review.

2

Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein.

Yin T, Wu YL, Sun HP, Sun GL, Du YZ, Wang KK, Zhang J, Chen GQ, Chen SJ, Chen Z. Yin T, et al. Among authors: wu yl. Blood. 2004 Dec 15;104(13):4219-25. doi: 10.1182/blood-2004-04-1433. Epub 2004 Aug 31. Blood. 2004. PMID: 15339852 Free article.

3

Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia.

Liu W, Guo M, Xu YB, Li D, Zhou ZN, Wu YL, Chen Z, Kogan SC, Chen GQ. Liu W, et al. Among authors: wu yl. Blood. 2006 Jan 15;107(2):698-707. doi: 10.1182/blood-2005-03-1278. Epub 2005 Sep 15. Blood. 2006. PMID: 16166593 Free article.

4

Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.

Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ. Yan H, et al. Among authors: wu yl. Haematologica. 2005 Dec;90(12):1607-16. Haematologica. 2005. PMID: 16330433

5

Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths.

Wu YL, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong JH, Chen GQ, Ségal-Bendirdjian E. Wu YL, et al. J Cell Sci. 2006 Jul 1;119(Pt 13):2797-806. doi: 10.1242/jcs.03001. Epub 2006 Jun 13. J Cell Sci. 2006. PMID: 16772337

6

c-Jun N-terminal kinase mediates AML1-ETO protein-induced connexin-43 expression.

Gao FH, Wang Q, Wu YL, Li X, Zhao KW, Chen GQ. Gao FH, et al. Among authors: wu yl. Biochem Biophys Res Commun. 2007 May 4;356(2):505-11. doi: 10.1016/j.bbrc.2007.03.009. Epub 2007 Mar 8. Biochem Biophys Res Commun. 2007. PMID: 17367753

7

Leukemia, an effective model for chemical biology and target therapy.

Chen GQ, Wang LS, Wu YL, Yu Y. Chen GQ, et al. Among authors: wu yl. Acta Pharmacol Sin. 2007 Sep;28(9):1316-24. doi: 10.1111/j.1745-7254.2007.00680.x. Acta Pharmacol Sin. 2007. PMID: 17723165 Review.

8

ent-Kaurane diterpenoids from Isodon scoparius.

Zhao Y, Pu JX, Huang SX, Wu YL, Yang LB, Xiao WL, Han QB, Chen GQ, Sun HD. Zhao Y, et al. Among authors: wu yl. J Nat Prod. 2009 Jan;72(1):125-9. doi: 10.1021/np800484j. J Nat Prod. 2009. PMID: 19072209

9

ent-Kaurane diterpenoids from Isodon pharicus.

Zhao Y, Pu JX, Huang SX, Ding LS, Wu YL, Li X, Yang LB, Xiao WL, Chen GQ, Sun HD. Zhao Y, et al. Among authors: wu yl. J Nat Prod. 2009 Jun;72(6):988-93. doi: 10.1021/np9000366. J Nat Prod. 2009. PMID: 19425589

10

[Hypoxia and its simulant CoCl(2) down-regulates Foxp3 expression independent from HIF-1alpha].

Wang XD, Liu CX, Wu YL, Chen J. Wang XD, et al. Among authors: wu yl. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):533-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19549358 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,251 results

Search Page